Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02054117 · ClinicalTrials.gov registry record
Association Between Haptoglobin Genotype and Brain Swelling
A clinical trial, sponsored by University of Florida.
- Terminated
- Registry status
- 9
- Enrollment target
NCT02054117: Clinical Trial study, sponsored by University of Florida.
NCT02054117 is a clinical trial that was terminated before completion, run by University of Florida. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02054117 was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
Intracerebral hemorrhage is bleeding into the brain and is a major cause of stroke and other complications. Brain injury from intracerebral hemorrhage occurs in two phases. The early phase involves the mechanical compression of brain tissue by the expanding hematoma. In a later phase, brain swelling develops causing further compression that may lead to brain herniation and death. This study investigates the neuroprotective role of haptoglobin, in minimizing the development of brain swelling following intracerebral hemorrhage.
Primary Outcome
Perihematomal edema will be measured by averaging the edema area over multiple slices and subtracting the hemorrhage area from the total lesion area.
Interventions
- OTHER Intracerebral Hemorrhage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-03 |
Why NCT02054117 stopped before completion
NCT02054117 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Intracerebral Hemorrhage is the first listed.
NCT02054117 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02054117 about?
NCT02054117 is a clinical study titled "Association Between Haptoglobin Genotype and Brain Swelling". Intracerebral hemorrhage is bleeding into the brain and is a major cause of stroke and other complications. Brain injury from intracerebral hemorrhage occurs in two phases. The early phase involves the mechanical compression of brain tissue by the expanding hematoma. In a later phase, brain swelling...
What is the current status of trial NCT02054117?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2014-03. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02054117?
The interventions under investigation include: Intracerebral Hemorrhage (OTHER).
Who is sponsoring clinical trial NCT02054117?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia